Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation

Míreanna Comhchosúla

• Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
  le: Duintjer Tebbens, Radboud J., et al.
  Foilsithe: (2016)
• Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
  le: Duintjer Tebbens, Radboud J., et al.
  Foilsithe: (2018)
• Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
  le: Thompson, Kimberly M., et al.
  Foilsithe: (2017)
• Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
  le: Thompson, Kimberly M., et al.
  Foilsithe: (2015)
• Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation
  le: Tebbens, Radboud J Duintjer, et al.
  Foilsithe: (2016)